The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Patel Kinnari since 2018.
This trader's CIK number is 1725929.
At the time of last reporting, Patel Kinnari was the See Remarks of Rocket Pharmaceuticals, Inc.. (stock ticker symbol RCKT).
Also see all insider trading activities at Rocket Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RCKT | 21,099 | $99,165 | 6,845 | $69,249 | 0 | $0 |
| 2024 | RCKT | 0 | $0 | 11,121 | $286,616 | 26,189 | $0 |
| 2023 | RCKT | 0 | $0 | 2,864 | $52,160 | 15,300 | $0 |
| 2021 | RCKT | 0 | $0 | 0 | $0 | 93,962 | $136,244 |
| 2020 | RCKT | 1,000 | $9,500 | 16,761 | $952,678 | 0 | $0 |
| 2018 | RCKT | 5,675 | $85,011 | 0 | $0 | 55,869 | $67,601 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-20 | RCKT | Sale | 767 | 6.45 | 4,944 |
| 2025-04-09 | RCKT | Buy | 21,099 | 4.70 | 99,165 |
| 2025-02-21 | RCKT | Sale | 6,078 | 10.58 | 64,305 |
| 2024-08-16 | RCKT | Sale | 3,989 | 18.50 | 73,812 |
| 2024-02-16 | RCKT | Sale | 7,132 | 29.84 | 212,804 |
| 2024-02-14 | RCKT | Option Ex | 26,189 | .00 | 0 |
| 2023-11-14 | RCKT | Option Ex | 3,989 | .00 | 0 |
| 2023-10-05 | RCKT | Option Ex | 3,333 | .00 | 0 |
| 2023-08-17 | RCKT | Sale | 1,534 | 15.47 | 23,732 |
| 2023-08-14 | RCKT | Option Ex | 3,989 | .00 | 0 |
| 2023-05-17 | RCKT | Sale | 1,330 | 21.38 | 28,428 |
| 2023-05-14 | RCKT | Option Ex | 3,989 | .00 | 0 |
| 2021-03-24 | RCKT | Option Ex | 93,962 | 1.45 | 136,244 |
| 2020-12-28 | RCKT | Sale | 16,761 | 56.84 | 952,678 |
| 2020-03-18 | RCKT | Buy | 1,000 | 9.50 | 9,500 |
| 2018-12-20 | RCKT | Option Ex | 55,869 | 1.21 | 67,601 |
| 2018-12-06 | RCKT | Buy | 5,675 | 14.98 | 85,011 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patel Kinnari (See Remarks of Rocket Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.